{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T10:26:20Z","timestamp":1770632780389,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.lungcan.2025.108732","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:10:51Z","timestamp":1757031051000},"page":"108732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Identification of poor prognostic factors using circulating extracellular vesicles in durvalumab consolidation therapy for locally advanced non-small cell lung cancer"],"prefix":"10.1016","volume":"208","author":[{"given":"Hirofumi","family":"Utsumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigehiro","family":"Yagishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Kawajiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Torasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayu","family":"Kiritani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Wakui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9090-801X","authenticated-orcid":false,"given":"Hidehito","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Araya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8916-7303","authenticated-orcid":false,"given":"Yu","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2025.108732_b0005","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential Radiochemotherapy in locally advanced non\u2013small-cell lung cancer","volume":"28","author":"Aup\u00e9rin","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108732_b0010","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108732_b0015","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108732_b0020","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108732_b0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jtho.2022.10.003","article-title":"Treatment characteristics and real-world progression-free survival in patients with unresectable stage III NSCLC who received durvalumab after chemoradiotherapy: findings from the PACIFIC-R study","volume":"18","author":"Girard","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2025.108732_b0030","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell Vesicles."},{"key":"10.1016\/j.lungcan.2025.108732_b0035","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.lungcan.2025.108732_b0040","first-page":"1390","article-title":"The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer","volume":"54","author":"Wang","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.lungcan.2025.108732_b0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/cells8020099","article-title":"Biology, pathophysiological role, and clinical implications of exosomes: a critical appraisal","volume":"8","author":"Jan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2025.108732_b0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41571-018-0036-9","article-title":"Extracellular vesicles in cancer\u2014implications for future improvements in cancer care","volume":"15","author":"Xu","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2025.108732_b0055","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2025.108732_b0060","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of Exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2025.108732_b0065","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1111\/1759-7714.15077","article-title":"Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non-small cell lung cancer from proteomic profiling of circulating extracellular vesicles","volume":"14","author":"Torasawa","year":"2023","journal-title":"Thorac Cancer."},{"key":"10.1016\/j.lungcan.2025.108732_b0070","unstructured":"Dako. PD-L1 IHC 22C3 pharmDx: interpretation manual. https:\/\/www.agilent.com\/cs\/library\/usermanuals\/public\/29158_pd-l1-ihc-22C3-pharmdx-nsclc-interpretation-manual.pdf."},{"key":"10.1016\/j.lungcan.2025.108732_b0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1021\/ac051495j","article-title":"Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation","volume":"78","author":"Bijlsma","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.lungcan.2025.108732_b0080","doi-asserted-by":"crossref","unstructured":"Kurimoto A, Kawasaki Y, Ueda T, Inuzuka T. Enhanced recovery of CD9-positive extracellular vesicles from human specimens by chelating reagent. https:\/\/doi.org\/10.1101\/2020.06.17.155861.","DOI":"10.1101\/2020.06.17.155861"},{"key":"10.1016\/j.lungcan.2025.108732_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13046-021-02230-z","article-title":"Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells","volume":"41","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108732_b0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12929-024-01004-x","article-title":"Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy","volume":"31","author":"Sun","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lungcan.2025.108732_b0095","first-page":"60","article-title":"Discovery of efficacy biomarkers for non-small cell lung cancer with first-line anti-PD-1 immunotherapy by data-independent acquisition mass spectrometry","volume":"208","author":"Chao","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lungcan.2025.108732_b0100","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00262-020-02788-1","article-title":"Blood serum amyloid a as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory \u201cFoRECATT\u201d study","volume":"70","author":"Di Noia","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.lungcan.2025.108732_b0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41392-022-01196-4","article-title":"S100A7 attenuates immunotherapy by enhancing immunosuppressive tumor microenvironment in lung squamous cell carcinoma","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.lungcan.2025.108732_b0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0092-8674(91)90143-M","article-title":"Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role","volume":"66","author":"Vleminckx","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2025.108732_b0115","first-page":"2171","article-title":"Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review","volume":"9","author":"Yu","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.lungcan.2025.108732_b0120","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1158\/1078-0432.CCR-23-2568","article-title":"Phase II study of durvalumab immediately after completion of chemoradiotherapy in unresectable stage III non-small cell lung cancer: TORG1937 (DATE Study)","volume":"30","author":"Nakamichi","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108732_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2021.11.013","article-title":"Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer","volume":"162","author":"Shirasawa","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2025.108732_b0130","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI81130","article-title":"Versatile roles of extracellular vesicles in cancer","volume":"126","author":"Kosaka","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lungcan.2025.108732_b0135","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1158\/1078-0432.CCR-17-2664","article-title":"Clinical significance of PD-L1+ exosomes in plasma of head and neck cancer patients","volume":"24","author":"Theodoraki","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108732_b0140","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s12967-019-2101-2","article-title":"Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients","volume":"17","author":"Li","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lungcan.2025.108732_b0145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/338438a0","article-title":"Identification of the long ubiquitin extension as ribosomal protein S27a","volume":"338","author":"Redman","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2025.108732_b0150","doi-asserted-by":"crossref","unstructured":"Hong SW, Kim SM, Jin DH, Kim YS, Hur DY. RPS27a enhances EBV-encoded LMP1-mediated proliferation and invasion by stabilizing of LMP1. Biochem Biophys Res Commun. 491 (2017) 303\u2013309. https:\/\/doi.org\/10. 1016\/j.bbrc.2017.07.105.","DOI":"10.1016\/j.bbrc.2017.07.105"},{"key":"10.1016\/j.lungcan.2025.108732_b0155","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2174\/0929867323666160418114600","article-title":"Structure and expression of different serum amyloid a (SAA) variants and their concentration-dependent functions during host insults","volume":"23","author":"De Buck","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.lungcan.2025.108732_b0160","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2025.108732_b0165","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2478\/jomb-2018-0036","article-title":"Soluble sPD-L1 and serum amyloid A1 as potential biomarkers for lung cancer","volume":"38","author":"Jovanovi\u0107","year":"2019","journal-title":"J Med Biochem."},{"key":"10.1016\/j.lungcan.2025.108732_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.905561","article-title":"SAA1 expression as a potential prognostic marker of the tumor microenvironment in glioblastoma","volume":"13","author":"Cao","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.lungcan.2025.108732_b0175","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.3390\/ijms24087505","article-title":"SAA1 has potential as a prognostic biomarker correlated with cell proliferation, migration, and an indicator for immune infiltration of tumor microenvironment in clear cell renal cell carcinoma","volume":"24","author":"Xu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lungcan.2025.108732_b0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.01.007","article-title":"Molecular regulation of autophagy in a pro-inflammatory tumour microenvironment: new insight into the role of serum amyloid a","volume":"59","author":"du Plessis","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.lungcan.2025.108732_b0185","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1038\/onc.2017.283","article-title":"S100A7: from mechanism to cancer therapy","volume":"36","author":"Padilla","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2025.108732_b0190","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/1523-1747.ep12484041","article-title":"Molecular cloning, occurrence, and expression of a novel partially secreted protein \u201cpsoriasin\u201d that is highly up-regulated in psoriatic skin","volume":"97","author":"Madsen","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lungcan.2025.108732_b0195","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/onc.2009.488","article-title":"S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer","volume":"29","author":"West","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2025.108732_b0200","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1158\/0008-5472.CAN-11-0669","article-title":"S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways","volume":"72","author":"Nasser","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2025.108732_b0205","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.18632\/aging.205665","article-title":"Correlation between S100A7 and immune characteristics, methylation, tumor stemness and tumor heterogeneity in pan-cancer and its role in chemotherapy resistance in breast cancer","volume":"16","author":"Li","year":"2024","journal-title":"Aging (Albany NY)"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:02:34Z","timestamp":1759539754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225006245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"alternative-id":["S0169500225006245"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108732","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of poor prognostic factors using circulating extracellular vesicles in durvalumab consolidation therapy for locally advanced non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108732"}}